Keynumbers for: IDL Biotech

 6/30/200912/31/20096/30/201012/31/20106/30/201112/31/20116/30/201212/31/2012
Number of months that the report spans612612612612
Total revenue (MSEK)9.69318.0908.0716.497.8515.339.1817.45
Earnings before interest and taxes (EBIT) (MSEK)0.177-0.360-0.95-2.24-0.60-3.39-2.14-5.48
Pre tax profit (PTP) (MSEK)0.199-0.315-0.992.24-1.03-3.52-2.23-5.58
Net Revenue (MSEK)0.177-0.360-0.99-2.34-1.13-3.52-2.23-5.58
Earnings per share (SEK)0.01-0.02-0.05-0.12-0.06-0.18-0.12-0.24
Dividend per share (SEK)--------
Owner's equity (MSEK)7.7057.1676.184.828.706.3010.567.21
Fixed assets (MSEK)4.6044.5474.845.355.315.295.385.41
Intangible assets (MSEK)-----4.684.885.02
Liquid assets (MSEK)6.8336.9128.077.038.358.1110.068.05
Total shareholder equity and liabilities (MSEK)----13.6613.3915.4413.46
Long time debts including distributions (MSEK)0--0.290.220.150.08-
Short term debt (MSEK)3.7314.292-6.737.274.756.954.806.25
The share's ratio value (SEK)0.800.800.800.800.400.400.40.4
Cash flow for the period (MSEK)----0.100.46-47.35-0.15
Number of shares (in millions)----19 057 04319 057 04319 057 04327 338 189
Average number of employees1111111111121113

  • Danderydsgatan 10
  • 114 86 Stockholm
  • Telefon: 08 - 545 038 00
  • Fax: 08 - 611 35 62
  • info(snabel-a)aktietorget(punkt)se